Clinical trial
A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of…
NCT00381394 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00381394 |
|---|---|
| Title | A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis. |
| Official title | A Phase II, Multi-centre, Open-label, Randomised Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral Sitamaquine Compared With Amphotericin B in the Treatment of Visceral Leishmaniasis Caused by L. Donovani in Endemic Areas. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leishmaniasis, Visceral |
| Intervention type | Drug |
| Interventions | sitamaquine |
| Enrollment | 61 |
| Start date | Aug 4, 2006 |
| Primary completion | Sep 14, 2007 |
| Completion | Sep 14, 2007 |
| First posted | Sep 27, 2006 |
| Last update posted | Sep 18, 2017 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: